Early Onset Colorectal Cancer Detection
for Colorectal Cancer
1 location in Duarte
Sponsor: City of Hope Medical Center
Sex: All·Age: 18 - 50·Accepts healthy volunteers
Code: NCT06342401·Recruiting·Listed Apr 2024
GI oncology Clinical Trials in Duarte, CA
As of September 2026, 53 paid clinical trials are recruiting for GI oncology in Duarte, California. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
53 clinical trials for GI oncology
·Clear filters· Email me when a new gi oncology trial opens in Duarte, CA.
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
for Hepatocellular Carcinoma
1 location in Duarte
Sponsor: City of Hope Medical Center
Sex: All·Age: 18+
Code: NCT06342414·Recruiting·Listed Apr 2024
Telehealth Intervention for Ostomy Self-Management
for Colorectal Cancer
1 location in Duarte
Sponsor: City of Hope Medical Center
Sex: All·Age: 18+
Code: NCT06528990·Phase 2·Recruiting·Listed Jul 2024
Phase II Trial of Lung Chemoemobolization
for Lung Non-Small Cell Carcinoma
Sites in Duarte +1 more location
Sponsor: City of Hope Medical Center
Sex: All·Age: 18+
Code: NCT05672108·Phase 2·Recruiting·Listed Jan 2023
Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer
for Colon Polyp
Sites in Duarte & Irvine
Sponsor: City of Hope Medical Center
Sex: Male·Age: 40 - 80
Code: NCT07790718·Recruiting·Listed Aug 27, 2026
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
for Gastric Cancer
Drug: Sonesitatug vedotin
Sites in Duarte, Fullerton +70 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT07431281·Phase 3·Recruiting·Listed Feb 2026
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
for Esophageal Squamous Cell Carcinoma
Sites in Duarte, Orange +8 more locations
Sponsor: Plexium, Inc.
Sex: All·Age: 18+
Code: NCT07284186·Phase 1·Recruiting·Listed Dec 2025
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
for Biliary Tract Cancer
Drug: Rilvegostomig
Sites in Duarte, Orange +34 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT07221253·Phase 3·Recruiting·Listed Oct 2025
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
for Non-small Cell Lung Cancer
Sites in Duarte, Los Angeles +16 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT06218914·Phase 1·Recruiting·Listed Jan 2024
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
for Non-small Cell Lung Cancer
Sites in Duarte, Santa Monica +12 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT05877599·Phase 1·Recruiting·Listed May 2023
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for Solid Tumor
Drug: INBRX-106
Sites in Duarte, Glendale +11 more locations
Sponsor: Inhibrx Biosciences, Inc
Sex: All·Age: 18+
Code: NCT04198766·Phase 1, Phase 2·Recruiting·Listed Dec 2019
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
for Breast Carcinoma
1 location in Duarte
Sponsor: City of Hope Medical Center
Sex: All·Age: 18+
Code: NCT06130826·Phase 1·Recruiting·Listed Nov 2023
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for HER2-positive Gastric Cancer
Drug: Rilvegostomig
Sites in Duarte, Upland +43 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT06764875·Phase 3·Recruiting·Listed Jan 2025